Finzati - Logo
STVN logo

Stevanato Group S.p.A.

STVN • Medical - Instruments & Supplies
$20.51
▼ -0.03 (-0.15%)
Current price
EarningsLatest report: Mar 31, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$5.60B
Growth
—
Cash Flow
2/5
Trend
Volatile
Evidence
Stable or improving margins · 11.8%Positive revenue growth · 7.0%Positive free cash flow · 0.08Manageable debt level · 0.32Healthy liquidity · 1.74
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 7, 2026, 12:00 AM UTCLast profile update: Aug 6, 2026, 1:48 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$20.51
Change-0.15%
Shares Out273.02M
Market Cap$5.60B
52W Range12.89 - 28.00
Beta0.78
P/E29.53
P/S12.10
P/B2.16
P/FCF694.00
EV/Sales13.10
EV/EBITDA55.09

Investment DNA

How strong this company looks for long-term investors

62
out of 100
Business Quality
Margins, moat, returns
71/100
Financial Strength
Debt, cash, stability
85/100
Growth Potential
Revenue and expansion
60/100
Price Attractiveness
Cheap or expensive today
48/100
Why this score▼
Stable or improving margins · 11.8%Positive revenue growth · 7.0%Positive free cash flow · 0.08Manageable debt level · 0.32Healthy liquidity · 1.74

Analyst view

Analyst sentiment and price target

STVN
Analyst sentiment
Based on 8 analyst votes · 2026-09-05
81/100
Bullish
Bullish
5
Hold
3
Bearish
0
Price Target
2026-08-06
Low
$17.50
Mean
$24.75
Median
$24.75
High
$32.00

Company Overview

IPO: 7/16/2021
Industry: Medical - Instruments & Supplies
P/B i: 2.16
Debt / Equity i: 0.32
Operating Margin: 16.07%
Net Margin: 11.78%
ROE i: -
ROIC: -

Financial Health

Score17 / 20
Debt / Equity: 0.32
Current Ratio: 1.74
Quick Ratio: 1.24
Status: Strong

Insider Transactions

Recent executive and insider activity

FEDERICI WILLIAM J
Transaction: 06/15/2026
SELL
Change
-1,493
Price
$17.09
Filing
06/26/2026
Type
SELL
Flynn Karen
Transaction: 06/15/2026
SELL
Change
-1,493
Price
$17.09
Filing
06/26/2026
Type
SELL
MOREL DONALD E JR
Transaction: 06/15/2026
SELL
Change
-1,493
Price
$17.09
Filing
06/26/2026
Type
SELL